Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 2/20 | 0.32 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.32 |
| ▸ | MARS1 | P56192 | 2/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alanine SCHEMBL5582473 | 0.90 | BHMT (0.33) | BHMTBHMT2MARS1METAP2METAP1 | |
| SCHEMBL3995868 | 0.88 | BHMT (0.35) | BHMTBHMT2MARS1METAP2METAP1 | |
| Threonine SCHEMBL6367180 | 0.84 | METAP2 (0.35) | BHMTBHMT2MARS1METAP2METAP1 | |
| SCHEMBL692980 | 0.82 | BHMT (0.31) | BHMTBHMT2 | |
| SCHEMBL8074429 | 0.81 | PTGS1 (0.39) | — | |
| Glycine SCHEMBL4005389 | 0.80 | BHMT (0.40) | BHMTBHMT2MARS1RNPEP | |
| SCHEMBL2260606 | 0.80 | RNPEP (0.44) | BHMTBHMT2MARS1RNPEP | |
| Leucine SCHEMBL16348668 | 0.79 | SLC7A5 (0.40) | BHMTBHMT2METAP2METAP1 | |
| Serine SCHEMBL5698241 | 0.78 | SLC7A5 (0.33) | — | |
| SCHEMBL5707660 | 0.77 | METAP2 (0.40) | BHMTBHMT2MARS1METAP2METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024074847-A1 | COMPOSITIONS FOR DETECTING BIOLOGICAL AGENTS | PATH SPRAY LTD (GB) | 2024-04-11 | — | — | WO | disclosed |
| WO-2024069175-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN ACTIVATING ENDOSOMAL PROTEASE CLEAVAGE SITE | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024069176-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN ACTIVATING EXOGENOUS PROTEASE CLEAVAGE SITE | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024069191-A1 | CLOSTRIDIAL NEUROTOXIN FOR USE IN A TREATMENT OF BLADDER PAIN SYNDROME | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024057031-A1 | CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS | IPSEN BIOPHARM LIMITED (GB) | 2024-03-21 | — | — | WO | disclosed |
| EP-4312964-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN EXOGENOUS ACTIVATION LOOP | Ipsen Biopharm Limited (GB) | 2024-02-07 | — | — | EP | disclosed |
| EP-4313120-A1 | TREATMENT OF PAIN & INFLAMMATORY DISORDERS | Ipsen Biopharm Limited (GB) | 2024-02-07 | — | — | EP | disclosed |
| EP-4305050-A2 | MODIFIED CLOSTRIDIAL NEUROTOXINS | Ipsen Biopharm Limited (GB) | 2024-01-17 | — | — | EP | disclosed |
| EP-4297773-A1 | CATALYTICALLY INACTIVE CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PAIN & INFLAMMATORY DISORDERS | Ipsen Biopharm Limited (GB) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023209327-A1 | BONT/A FOR USE IN TREATING A FACIAL DYSTONIA | IPSEN BIOPHARM LIMITED (GB) | 2023-11-02 | — | — | WO | disclosed |
| WO-1997033913-A1 | CYTOKINE-RECEPTOR EXPRESSED IN TESTIS CELLS | ZYMOGENETICS, INC. (US) | 1997-09-18 | — | — | WO | disclosed |
| WO-1997032984-A1 | DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE | ZYMOGENETICS, INC. (US) | 1997-09-12 | — | — | WO | disclosed |
| WO-1997025424-A1 | OB PROTEIN RECEPTOR AND RELATED COMPOSITIONS AND METHODS | AMGEN INC. (US) | 1997-07-17 | — | — | WO | disclosed |
| EP-0745125-A1 | HEMATOPOIETIC PROTEIN AND MATERIALS AND METHODS FOR MAKING IT | ZymoGenetics, Inc. (US) | 1996-12-04 | — | — | EP | disclosed |
| EP-0723456-A1 | METHODS FOR STIMULATING ERYTHROPOIESIS USING THROMBOPOIETIN | THE UNIVERSITY OF WASHINGTON (US) | 1996-07-31 | — | — | EP | disclosed |
| WO-1996020955-A1 | PURIFIED THROMBOPOIETIN AND METHOD OF MAKING IT | ZYMOGENETICS, INC. (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996017062-A1 | LOW MOLECULAR WEIGHT THROMBOPOIETIN | ZYMOGENETICS, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1996017067-A1 | METHOD FOR SECRETING THROMBOPOIETIN POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1995021920-A1 | HEMATOPOIETIC PROTEIN AND MATERIALS AND METHODS FOR MAKING IT | ZYMOGENETICS, INC. (US) | 1995-08-17 | — | — | WO | disclosed |
| WO-1995021626-A1 | METHODS FOR STIMULATING ERYTHROPOIESIS USING THROMBOPOIETIN | UNIVERSITY OF WASHINGTON (US) | 1995-08-17 | — | — | WO | disclosed |